CagriSema: difference between revisions
Diff·revision 10 → 11·13:09, 25 Feb 2025
Difference between revision 10 and revision 11 of CagriSema. 6 lines changed; the page grew by 111 bytes.
| Revision 10 — 04:29, 8 Feb 2025 Hedgerow_Hal (talk) add the excipient list from the labelling 3,776 bytes +787 | Revision 11 — 13:09, 25 Feb 2025 ComparisonCato (talk) de-duplicate a repeated sentence 3,887 bytes +111 | ||
|---|---|---|---|
| 32 | <ref name="lau2021">Lau DCW, Erichsen L, Francisco AM, et al. "Once-weekly cagrilintide for weight management in people with overweight and obesity." ''The Lancet'' 398(10317):2160–2172 (2021). PMID 34798060.</ref> | 32 | <ref name="lau2021">Lau DCW, Erichsen L, Francisco AM, et al. "Once-weekly cagrilintide for weight management in people with overweight and obesity." ''The Lancet'' 398(10317):2160–2172 (2021). PMID 34798060.</ref> |
| 33 | 33 | ||
| + | 34 | == See also == | |
| + | 35 | * [[Cagrilintide]] | |
| + | 36 | * [[Semaglutide]] | |
| + | 37 | * [[Amylin receptor agonist]] | |
| + | 38 | * [[Dual incretin agonist]] | |
| + | 39 | ||
| 34 | {{DEFAULTSORT:CagriSema}} | 40 | {{DEFAULTSORT:CagriSema}} |
| 35 | [[Category:Amylin analogues]] | 41 | [[Category:Amylin analogues]] |